Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ENCORE: Eliglustat tartrate in Gaucher Disease Type 1
NCT00943111Phase 3Completed
- Sponsor
- Sanofi
- Start
- Sep 2009
- Primary completion
- Nov 2012
- Modality
- Small Molecules
- Countries
- 12
01
Overview
A Phase 3 trial of eliglustat in Gaucher disease type 1 (GD1), sponsored by Sanofi. Started Sep 2009; status: completed.
02
Drugs
eliglustat
03
Conditions
Gaucher disease type 1 (GD1)
Beyond the preview
Go deeper on NCT00943111.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00943111.